Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1996-12-03
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3152
Patent
active
055808743
ABSTRACT:
Them is disclosed compounds and pharmaceutical compositions that is R enantiomer of an .omega.-1 alcohol of a straight chain alkyl (C.sub.5-8) substituted at the 1-position of 3,7-disubstituted xanthine. The inventive compounds are effective in treating the side effects of immunosuppressive agent and interleukin-2 therapy.
REFERENCES:
patent: 3373433 (1968-03-01), Mohler et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4525309 (1985-06-01), Matteson et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5112827 (1992-05-01), Saunders et al.
patent: 5118500 (1992-06-01), H anel et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: 5310666 (1994-05-01), Aretz et al.
patent: 5409935 (1995-04-01), Schubert et al.
Bianco et al., Blood, vol. 78, No. 5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", 1991.
Davis et al., Applied And Environmental Microbiology, vol. 48, No. 2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", 1984.
Davis et al., Xenobiotica, vol. 15, No. 12, pp. 1001-1010, "Microbial Models of Mammalian Metabolism: Stereospecificity of Ketone Reduction with Pentoxifylline", 1985.
Matteson et al., J. Am. Chem. Soc., vol. 108, pp. 810-819, "99% Chirally Selective Syntheses via Pinanediol Boronic Ester: Insect Pheromones, Diols, and an Amino Alcohol", 1986.
Soundarajan et al., J. Org. Chem., vol. 55, pp. 2274-2275, "Hydroboration with Boron Halides and Trialkylsilanes", 1990.
Bianco James A.
Porubek David
Singer Jack
Woodson Paul
Cell Therapeutics Inc.
Criares Theodore J.
Faciszewski Stephen
LandOfFree
Enatiomerically pure hydroxylated xanthine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enatiomerically pure hydroxylated xanthine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enatiomerically pure hydroxylated xanthine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-785818